Daily Equity Report 16 May 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 16 THMAY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK - The benchmark indices ended lower in the volatiletradingon May 15 with Nifty closedbelow11,200mark.Atclose,theSensexwasdown NIFTY 203.65 pointsat37,114.88,whileNiftywasdown65points CLOSE PREVIOUS at 11,157. About 982 shares have advanced, 1544 shares NIKKEI declined, and 176 shares are unchanged. Yes Bank, Tata Motors,ZeeEntertainment,JSWSteelandGailwerethetop losersontheNifty,whilegainers wereBajajFinance,Eicher 2092.78 2081.84 Motors,UPL,IOCandIndiabullsHousing.Amongthesectors, SECTORIAL INDICES metal index slipped 2 percent followed by auto, infra, CLOSE CHANGE (%) pharma,FMCGandbank. GLOBALFACE CNX 100 S&P CNX 500 9160.10 ! 4585.00 AsianMarket- Asianmarketsfinishedbroadlyhighertoday with shares in China leading the region. The Shanghai Compositeisup1.91%whileJapan'sNikkei225isup0.58% CNX 200 5773.30 BANK NIFTY andHongKong'sHangSengisup0.52%. TOP GAINERS ! U.S.Market– NorthandSouthAmericanmarketsfinished higher onTuesdaywithsharesinU.S.leadingtheregion.The CLOSE CHANGE (%) BAJFINANCE 4.52 S&P500isup0.80%whileMexico'sIPCisup0.67%and Brazil'sBovespaisup0.40%. 4.23 UPL 1.56 ! Europeanmarkets– Europeanmarketsaremixed.TheFTSE 100 ishigherby0.04%,whiletheDAXisleadingtheCAC40 BAJAJFINSV 1.16 lower.Theyaredown0.44%and0.35%respectively. TOP LOSERS CLOSE CHANGE (%) YESBANK 142.35 -8.66 170.70 -7.48 322.60 -6.84 267.00 -4.98 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 4.52 BAJFINANCE PIVOT POINTS 0.91 S3 10893 S2 11043 R1 11250 R2 11343 R3 11493 IOC 11100 11193 0.78 ITC S1-11033 S2-10900 R1-11300 R2-11420 0.76 CLOSE (%) -8.66 -3.64 GAIL COALINDIA -3.35 -3.26 NET BUY (CR.) NET STRATEGY SELL ON RISE SELL (CR) 4696.49 PIVOT POINTS P 28759 S1 28440 R1 28925 R2 R3 29728 DII 5086.56 27791 28275 29244 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! ! ZeeMediadeclines11%postQ4FY19 results DrReddyslaunchesDaptomycinfor InjectionintheUS Dr.ReddysLaboratoriesinitsfilingtotheexchangeson Wednesday informed that the company has launched DaptomycinforInjection,500mg/vialsingle-dosevial,a therapeutic equivalent generic version of Cubicin for Injection, approved by the US Food and Drug Administration (USFDA). The Cubicin for Injection (daptomycin for injection) brand and generic had US sales of ~$640.8mn MAT for the most recent twelve months ending in March 2019, according to IQVIA Health. ZeeMediadeclined11%onWednesdayafterthecompany registered a net loss ofRs86.66cr vs PAT ofRs11.2cra yearago.The revenueofZeeMediatumbled3.9%inthe January-March quarter at Rs169.35cr, compared to Rs176.22crinQ4FY18,thecompanysaidinapressnote after markets hours to the exchanges on Tuesday. The companysPATstoodatRs13.17crforFY19,whichisdown 73.1%yoyvs.Rs49cr.Consolidatedoperatingrevenuein FY19grewby19.8%toRs686.92crfromRs573.48crinthe FY18. ! UCOBankslips~4%afterQ4netloss SharesofUCOBankslipped3%inWednesday'slate morningtradeontheBSEafterthebankpostedanetloss ofRs1,552crinthequarterendedMarch2019asagainsta netlossofRs2,134.36crduringthepreviousquarter endedMarch2018.Theprovisionsfornon-performing assets(NPAs)inthelastquarterstoodatRs2,602cras againstRs3,134crinthesameperiod ofFY18.Forthefull year,netlossreportedtoRs4,321.09crintheyearended March2019asagainstanetlossofRs4,436.37crduring thepreviousyearendedMarch2018. ! OrchidPharmagetsANDAnodfrom USFDAforRisedronateSodiumtablets OrchidPharmahasreceivedANDAapprovalfromUSFDAfor RisedronateSodiumTabletsUSP,30mgand35mg,thecompany saidinthefiling.TheannouncementmadeonMay14,after markethours.Risedronatesodiumtabletsareabisphosphonate indicatedforthe treatmentandpreventionofOsteoporosis,the companysaid.OrchidPharmaLtdiscurrentlytradingatRs4.02, upbyRs0.19or4.96%fromitspreviousclosingofRs3.83onthe BSE.ThescripopenedatRs4andhastouchedahighandlowof Rs4.02andRs4respectively. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : LTI DATE : 16/05/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY LTI IN CASH ABOVE 1759 TGT 1785 SL 1735 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.